logo
67th Session of the APO Governing Body in Indonesia Sets Strategic Direction for a Unified Productivity Vision

67th Session of the APO Governing Body in Indonesia Sets Strategic Direction for a Unified Productivity Vision

Yahoo26-05-2025
JAKARTA, Indonesia, May 26, 2025--(BUSINESS WIRE)--The Asian Productivity Organization (APO) convened the 67th Session of the Governing Body (GBM), 20–22 May 2025 in Jakarta, hosted by the Government of the Republic of Indonesia. This annual session brought together over 50 delegates representing APO member governments to discuss the APO's strategic direction and ensure the organization's continued credibility, effectiveness, and relevance amid a rapidly evolving productivity landscape.
The 67th GBM saw numerous important leadership transitions. APO Director for India Amardeep Singh Bhatia took on the position of APO Chair for 2025–26, taking over from APO Director for Fiji Jone Maritino Nemani. APO Director for Indonesia Agung Nur Rohmad and APO Director for the Islamic Republic of Iran Dr. Mohammad Saleh Owlia were also appointed as First and Second Vice Chairs, respectively.
The Governing Body expressed its continued confidence in the forward-looking leadership of incumbent Secretary-General Dr. Indra Pradana Singawinata, nominated by the Government of Indonesia, by electing him for a second term as Secretary-General from September 2025 to September 2028.
In his opening statement, APO Chair Bhatia emphasized India's commitment to the APO's vision of inclusive, innovation-led, sustainable productivity growth in the Asia-Pacific region as a founding member of the APO. He also reaffirmed India's dedication to enhancing the institutional efficiency and strategic alignment of the APO through its chairmanship and praised the significant progress made on the development of the Green Productivity (GP) 2.0 ecosystem.
The inaugural session of the GBM was graced by H.E. Minister of Manpower of the Republic of Indonesia Professor Yassierli. In his inaugural speech, Minister Professor Yassierli underscored the urgency of responding collectively to a rapidly changing global landscape marked by economic uncertainty, technological disruption, and mounting sustainability pressures. Under such conditions, productivity should not be treated as competition among nations but rather as a shared journey rooted in mutual respect, shared knowledge, and solidarity. Professor Yassierli noted the APO's crucial role in facilitating solidarity among its members by serving as a platform for practical cooperation through locally relevant and globally informed solutions such as GP.
The 67th GBM featured in-depth deliberations on several strategic priorities to guide the APO's trajectory in the coming years. Central among these were the deliberations on the APO post-2025 vision framework, which will set the foundation for the APO's activities beyond 2025. The development of the GP 2.0 ecosystem was also discussed, and the Governing Body welcomed the recommendations from the Green Productivity Advisory Council Annual Meeting, which convened in Osaka, Japan, from 14 to 15 April 2025.
Other key topics included the proposed revisions to the membership contribution formula based on the task force's recommendations to ensure fairness and sustainability in APO financing. Strategies to strengthen the Secretariat's digital capabilities through improved systems and expanded access to APO services were also discussed. The GBM also reviewed the progress made in implementing remediation actions based on the independent third-party assessment, reaffirming the APO's commitment to good governance, transparency, and institutional effectiveness. Additional milestones were the accreditation of the Development Academy of the Philippines Certification Body to operate the Productivity Specialist scheme and the expansion of Indonesia's national certification body scope. The GBM also welcomed observers from the United Nations Industrial Development Organization and the Ministry of Economy and Finance of the Republic of Uzbekistan, signaling the APO's growing engagement with nonmembers and international organizations operating in the Asia-Pacific region.
The highly successful 67th GBM was concluded on a celebratory note as the Governing Body warmly welcomed APO Chair Bhatia's announcement of India's readiness to host the 68th GBM in 2026.
About the APO
The APO is an intergovernmental organization dedicated to improving productivity and socioeconomic development in the Asia-Pacific region through policy advisory services, capacity-building initiatives, knowledge sharing, and cooperation. It is nonpolitical, nonprofit, and nondiscriminatory.
Established in 1961 with eight founding members, the APO currently comprises 21 member economies.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250526891094/en/
Contacts
The Asian Productivity Organization (APO)Contact: pr@apo-tokyo.org.Website: https://www.apo-tokyo.org.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Higher Expenses to Hurt Apollo's Q2 Earnings, AUM Growth to Aid
Higher Expenses to Hurt Apollo's Q2 Earnings, AUM Growth to Aid

Yahoo

time6 hours ago

  • Yahoo

Higher Expenses to Hurt Apollo's Q2 Earnings, AUM Growth to Aid

Apollo Global Management, Inc. APO is scheduled to announce second-quarter 2025 results on Aug. 5, before market open. APO's quarterly earnings and revenues are expected to have increased from the year-ago reported the last reported quarter, Apollo's earnings lagged the Zacks Consensus Estimate. Results were primarily affected by a rise in expenses. Nonetheless, an increased assets under management (AUM) balance acted as a tailwind in the earnings beat the consensus estimate in two of the trailing four quarters and missed twice, the average earnings surprise being 3.53%. Apollo Global Management Inc. Price and EPS Surprise Apollo Global Management Inc. price-eps-surprise | Apollo Global Management Inc. Quote The Zacks Consensus Estimate for APO's earnings of $1.85 has been unchanged over the past seven days. The figure indicates a rise of 12.8% from the year-ago quarter's consensus estimate for sales is pegged at $1.01 billion, suggesting a year-over-year rise of 8.4%. Key Factors & Estimates for APO in Q2 Supported by overall asset inflows on the back of volatile markets, the company's total AUM balance is expected to have improved. Also, its diversified asset classes, client bases and geographies are likely to have supported AUM growth in the quarter to be Zacks Consensus Estimate for the company's total AUM in the second quarter of 2025 is pegged at $812.1 billion, which suggests a sequential rise of 3.5%.The consensus estimate for management fees (segment earnings) is pegged at $794.2 million, indicating a sequential rise of 3.1%.In the second quarter of 2025, the consensus estimate for fee-related performance fees (segment earnings) is pegged at $55.6 million, indicating a rise of 3% from the previous quarter's reported consensus estimate for net capital solutions fees and other (segment earnings) is pinned at $162.3 million, indicating a sequential decline of 5.4%.On the cost front, the company's ongoing investments in building its capital formation and credit investing teams, along with charges related to mergers, are likely to have kept the expense base elevated in the second quarter. What Our Model Predicts for APO Per our proven model, the chances of Apollo beating estimates this time are low. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That is not the case here, as you can see can uncover the best stocks to buy or sell before they are reported with our Earnings ESP ESP: Apollo has an Earnings ESP of -0.36%.Zacks Rank: APO currently has a Zacks Rank of 4 (Sell).You can see the complete list of today's Zacks #1 Rank stocks here. Performance of Other Asset Managers Invesco's IVZ second-quarter 2025 adjusted earnings of 36 cents per share lagged the Zacks Consensus Estimate of 40 cents. Moreover, the bottom line declined 16.3% from the prior-year results were adversely impacted by higher adjusted operating expenses. However, a rise in adjusted net revenues was a tailwind. An increase in the AUM balance due to solid inflows was a positive too. Blackstone's BX second-quarter 2025 distributable earnings of $1.21 per share surpassed the Zacks Consensus Estimate of $1.10. The figure reflects a rise of 26% from the prior-year benefited from higher segment revenues and a rise in AUM balance. However, an increase in GAAP expenses was a headwind for BX. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Blackstone Inc. (BX) : Free Stock Analysis Report Invesco Ltd. (IVZ) : Free Stock Analysis Report Apollo Global Management Inc. (APO) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Quanterix Announces Cooperation Agreement with Kent Lake Capital
Quanterix Announces Cooperation Agreement with Kent Lake Capital

Business Wire

timea day ago

  • Business Wire

Quanterix Announces Cooperation Agreement with Kent Lake Capital

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation ('Quanterix' or the 'Company') (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it has entered into a cooperation agreement (the 'Agreement') with Kent Lake Partners LP (together with its affiliates, 'Kent Lake'). The Company has committed to appointing a new independent director by December 1, 2025. The new director will be identified through a comprehensive search process in which both Kent Lake and the Board of Directors (the 'Board') shall have meaningful participation. In addition, the Company will seek approval at the 2025 Annual Meeting of Stockholders (the 'Annual Meeting') to declassify its Board and will amend its bylaws to adopt a majority voting standard for uncontested director elections. Under the terms of the Agreement, Kent Lake has agreed to withdraw its director nominations and shareholder proposals previously submitted in connection with the Annual Meeting and will support the Board's candidates. In addition, Kent Lake has agreed to customary standstill and voting commitments until thirty days prior to the nomination deadline for Quanterix's 2027 Annual Meeting. 'We are pleased to have reached a constructive agreement with Kent Lake that will allow the Board and management team to remain fully focused on executing the Company's strategy, navigating the dynamic industry environment and maximizing the benefits of the Akoya transaction,' said William P. Donnelly, Chairman of the Quanterix Board. 'We look forward to working with Kent Lake to identify a new director who can help us unlock the Company's full potential and advance our goal of changing the way disease is detected, understood and treated.' Benjamin Natter, Managing Member of Kent Lake, said, 'We are confident that the addition of a new independent director and governance enhancements will benefit the Company and its stockholders and help position Quanterix for continued success.' The full cooperation agreement between Quanterix and Kent Lake will be filed with the U.S. Securities and Exchange Commission on a Current Report on Form 8-K. About Quanterix Quanterix is a global leader in ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development. Its proprietary Simoa® technology delivers industry-leading sensitivity, allowing researchers to detect and quantify biomarkers in blood and other fluids at concentrations far below traditional limits. With more than 3,400 peer-reviewed publications, Quanterix has been a trusted partner to the scientific community for nearly two decades. In 2025, Quanterix acquired Akoya Biosciences, The Spatial Biology Company®, adding multiplexed tissue imaging with single-cell resolution to its portfolio and 1,396 installed instruments. Together, the combined company offers a uniquely integrated platform that connects biology across blood and tissue—advancing precision medicine from discovery to diagnostics. Learn more at Additional Information and Where to Find It The Company intends to file a definitive proxy statement on Schedule 14A, an accompanying WHITE proxy card and other relevant documents with the SEC in connection with the solicitation of proxies from the Company's stockholders for the Company's Annual Meeting. STOCKHOLDERS OF THE COMPANY ARE STRONGLY ENCOURAGED TO READ THE COMPANY'S DEFINITIVE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ALL OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Stockholders may obtain a copy of the definitive proxy statement, an accompanying WHITE proxy card, any amendments or supplements to the definitive proxy statement and other documents filed by the Company with the SEC at no charge at the SEC's website at Copies will also be available at no charge on the Company's investor relations website at or by contacting the Company's Investor Relations department at as soon as reasonably practicable after such materials are electronically filed with, or furnished to, the SEC. Participants in the Solicitation The Company, its directors and certain of its executive officers are participants in the solicitation of proxies from the Company's shareholders in connection with matters to be considered at the Annual Meeting. Information regarding the direct and indirect interests, by security holdings or otherwise, of the Company's directors and executive officers is included in the sections entitled 'Security Ownership of Certain Beneficial Owners and Management,' 'Management and Corporate Governance' and 'Executive Officer and Director Compensation' of the Company's Proxy Statement on Schedule 14A for its 2024 annual meeting of shareholders, filed with the SEC on April 15, 2024 (available here); in the sections entitled 'Directors, Executive Officers and Corporate Governance,' 'Executive Compensation—Executive Officer and Director Compensation Tables' and 'Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters—Security Ownership of Certain Beneficial Owners and Management' of the Company's Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 17, 2025 (available here) (as amended on April 30, 2025 (available here)), and in the Company's Current Report on Form 8-K filed with the SEC on July 8, 2025 (available here). Changes to the direct or indirect interests of the Company's directors and executive officers are set forth in Initial Statements of Beneficial Ownership filed with the SEC on May 2, 2025, May 19, 2025, June 3, 2025, June 10, 2025, June 17, 2025, July 7, 2025, July 17 for Mr. Masoud (available here, here, here, here, here, here and here); on May 19, 2025, June 17, 2025 and July 17, 2025 for Ms. Vandana (available here, here and here); on June 9, 2025 and July 2, 2025 for Mr. Donnelly (available here and here); on June 9, 2025, June 13, 2025 and July 2, 2025 for Mr. Walt (available here, here and here); on July 2, 2025 for Mr. Meister (available here); on July 9, 2025 and July 10, 2025 for Mr. Mendel (available here and here); and on July 9, 2025 and July 10, 2025 for Ms. Lai-Goldman (available here and here). These documents are available free of charge as described above. Updated information regarding the identities of potential participants and their direct or indirect interests, by security holdings or otherwise, in the Company will be set forth in the definitive proxy statement for the Annual Meeting and other relevant documents to be filed with the SEC, if and when they become available. Cautionary Statement Regarding Forward-Looking Statements Statements included in this press release which are not historical in nature or do not relate to current facts are intended to be, and are hereby identified as, forward-looking statements for purposes of the safe harbor provided by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among other things, statements about Quanterix's future business outlook, operations, strategy and financial performance. Words and phrases such as 'may,' 'approximately,' 'continue,' 'should,' 'expects,' 'projects,' 'anticipates,' 'is likely,' 'look ahead,' 'look forward,' 'believes,' 'will,' 'intends,' 'estimates,' 'strategy,' 'plan,' 'could,' 'potential,' 'possible' and variations of such words and similar expressions are intended to identify such forward-looking statements. Forward-looking statements are subject to certain risks and uncertainties that are difficult to predict with regard to, among other things, timing, extent, likelihood and degree of occurrence, which could cause actual results to differ materially from anticipated results. Such risks and uncertainties include, among others, the following possibilities with respect to Quanterix's future business, operations, strategy and financial performance: risks related to the impact of recent U.S. government policies, including reductions in federal research funding and increased tariffs; risks that we may not realize the expected benefits of our cost reduction actions; risks associated with the anticipated timing for launch of, and features of, Quanterix's next-generation instrument, Simoa ONE; risks that Quanterix may fail to realize the anticipated benefits and synergies of its recent acquisition of Emission, Inc.; that Quanterix's estimates regarding expenses, future revenues, capital requirements, and needs for additional financing could be incorrect; risks related to the restatement of Quanterix's consolidated financial statements, including risks of increased costs and the increased possibility of legal proceedings and regulatory inquiries, sanctions, or investigation; risks related to Quanterix's ability to maintain effective internal control over financial reporting and disclosure controls and procedures, including its ability to remediate existing material weaknesses in its internal control over financial reporting and the timing of any such remediation; Quanterix's ability to realize the intended benefits of its assay redevelopment program; and Quanterix's ability to retain and expand its customer base and achieve sufficient market acceptance of its products. Additional factors that could cause results to differ materially from those described above can be found in the Proxy Statement/Prospectus, and in periodic reports filed by Quanterix and Akoya with the SEC, including the 'Risk Factors' sections contained therein, which are available on the SEC's website at All forward-looking statements, expressed or implied, included in this press release are expressly qualified in their entirety by the cautionary statements contained or referred to herein. If one or more events related to these or other risks or uncertainties materialize, or if Quanterix's underlying assumptions prove to be incorrect, actual results may differ materially from what Quanterix anticipates. Quanterix cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made and are based on information available at that time. Quanterix does not assume any obligation to update or otherwise revise any forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements were made or to reflect the occurrence of unanticipated events except as required by federal securities laws.

Tesla Approves Interim Stock Award for Musk Ahead of Pay Vote
Tesla Approves Interim Stock Award for Musk Ahead of Pay Vote

Bloomberg

timea day ago

  • Bloomberg

Tesla Approves Interim Stock Award for Musk Ahead of Pay Vote

Tesla Inc. approved an interim stock award of 96 million shares for Chief Executive Officer Elon Musk and said it would put a longer-term CEO compensation strategy ahead of a vote at the EV maker's Nov. 6 annual meeting. Shares in Tesla rose 2.6% as the Tesla board emphasized the importance of retaining Musk at the helm. The board said the reward was a first step 'good faith' payment to Musk, in a filing released Monday. 'After all, a 'deal is a deal.''

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store